As shown, the lack of in vitro or in vivo experimental models specifically investigating PSMA expression on the neovasculature and on neoplastic cells has limited the development of imaging and therapeutic approaches using PSMA targeting for other tumour models. Here, FOLH1 is linked to neoplasm.